NETosis provides the link between activation of neutrophils on hemodialysis membrane and comorbidities in dialyzed patients.

Marie Korabecna, Vladimir Tesar
Author Information
  1. Marie Korabecna: Department of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Albertov 4, 128 00, Prague, Czech Republic. marie.korabecna@lf1.cuni.cz. ORCID
  2. Vladimir Tesar: Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic.

Abstract

INTRODUCTION: Neutrophil extracellular traps (NETs) are formed by activated neutrophils during the process of NETosis in which the nuclear material is released into extracellular space, including DNA molecules, citrullinated histones, and neutrophil granule enzymes, such as elastase. This material forms networks that are able not only to physically entrap bacteria but also to provide elevated concentration of bactericidal components. Over the last years, it has become clear that NETs can also be formed under numerous sterile inflammatory conditions, i.e., thrombosis, cancer, SLE, atherosclerosis, and diabetes.
METHOD: We reviewed studies published until July 2016 to find possible associations between elevated cell-free DNA levels in dialyzed patients and the process of NETosis and its consequences.
RESULTS: The process of NETosis, its elevated activation, or impaired clearance provides the link between clinical conditions and elevated levels of cell-free DNA found in plasma after the hemodialytic procedure which itself is able to activate neutrophils via platelets and ROS formation. NETs stimulate thrombosis and endothelial damage, and their formation may contribute to the development of spectrum of comorbidities described in dialyzed patients.
CONCLUSION: The study of plasma cell-free DNA levels together with markers of NETosis could contribute to the evaluation of the influence of hemodialysis on the immune system of patients.

Keywords

References

  1. Front Immunol. 2013 Mar 06;4:48 [PMID: 23508552]
  2. J Immunol. 2011 Jul 1;187(1):538-52 [PMID: 21613614]
  3. Cell Mol Life Sci. 2014 Nov;71(21):4179-94 [PMID: 25070012]
  4. Autoimmunity. 2012 Dec;45(8):593-6 [PMID: 22928646]
  5. J Crit Care. 2014 Dec;29(6):1133.e1-5 [PMID: 25128442]
  6. J Clin Endocrinol Metab. 2003 Apr;88(4):1753-9 [PMID: 12679469]
  7. J Comp Pathol. 2013 Jan;148(1):22-32 [PMID: 22789860]
  8. Circ Res. 2015 Mar 27;116(7):1182-92 [PMID: 25547404]
  9. Blood Rev. 2016 Jul;30(4):257-61 [PMID: 26776504]
  10. Semin Immunopathol. 2013 Jul;35(4):465-80 [PMID: 23595413]
  11. Blood. 2011 Jan 20;117(3):953-9 [PMID: 20974672]
  12. Front Immunol. 2013 Jun 24;4:160 [PMID: 23805137]
  13. Nephrol Dial Transplant. 2012 Mar;27(3):902-5 [PMID: 22167588]
  14. J Cell Biol. 2007 Jan 15;176(2):231-41 [PMID: 17210947]
  15. Blood. 2012 Oct 11;120(15):3007-18 [PMID: 22932797]
  16. Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12493-8 [PMID: 16891410]
  17. J Leukoc Biol. 2011 Oct;90(4):771-6 [PMID: 21712395]
  18. Clin Chim Acta. 2016 Aug 1;459:89-93 [PMID: 27259468]
  19. Clin Dev Immunol. 2012;2012:720768 [PMID: 23227088]
  20. Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):2032-40 [PMID: 23818485]
  21. Carcinogenesis. 2012 May;33(5):949-55 [PMID: 22425643]
  22. Cell Death Differ. 2009 Nov;16(11):1438-44 [PMID: 19609275]
  23. J Immunol. 2008 Feb 1;180(3):1895-902 [PMID: 18209087]
  24. J Immunol. 2010 Dec 15;185(12):7413-25 [PMID: 21098229]
  25. Nat Med. 2012 Sep;18(9):1386-93 [PMID: 22922410]
  26. Mol Cell Biochem. 2012 Feb;361(1-2):289-96 [PMID: 22048812]
  27. Blood Purif. 2016;41(1-3):64-71 [PMID: 26517236]
  28. Acta Diabetol. 2015 Jun;52(3):497-503 [PMID: 25387570]
  29. J Leukoc Biol. 2012 Mar;91(3):369-76 [PMID: 22131345]
  30. Science. 2015 Jul 17;349(6245):316-20 [PMID: 26185250]
  31. J Allergy Clin Immunol. 2011 May;127(5):1243-52.e7 [PMID: 21376380]
  32. Kidney Int. 2006 Apr;69(8):1416-23 [PMID: 16531979]
  33. Clin Chem Lab Med. 2006;44(12):1410-5 [PMID: 17163815]
  34. Blood. 2015 Mar 19;125(12):1948-56 [PMID: 25624317]
  35. Blood. 2012 Feb 2;119(5):1214-6 [PMID: 22210873]
  36. J Clin Invest. 2013 Jul 1;:null [PMID: 23863628]
  37. J Mol Biol. 2008 Apr 4;377(4):1053-66 [PMID: 18295791]
  38. Nephrol Dial Transplant. 2005 Jun;20(6):1048-56 [PMID: 15814534]
  39. PPAR Res. 2014;2014:643189 [PMID: 25371664]
  40. Science. 2004 Mar 5;303(5663):1532-5 [PMID: 15001782]
  41. Nat Med. 2007 Apr;13(4):463-9 [PMID: 17384648]
  42. Semin Dial. 2016 Jul;29(4):263-4 [PMID: 27061506]
  43. FEBS Lett. 2010 Jul 16;584(14):3193-7 [PMID: 20541553]
  44. Nephrol Dial Transplant. 2012 Oct;27(10):3929-35 [PMID: 22833622]
  45. Nat Rev Mol Cell Biol. 2014 Feb;15(2):135-47 [PMID: 24452471]
  46. Clin Chem. 2006 Mar;52(3):523-6 [PMID: 16510434]
  47. Atherosclerosis. 2014 Oct;236(2):448-55 [PMID: 25173070]
  48. Am J Hum Genet. 1999 Jan;64(1):218-24 [PMID: 9915961]
  49. Autoimmun Rev. 2015 Jul;14(7):633-40 [PMID: 25797532]
  50. Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):13076-81 [PMID: 22826226]
  51. Nutr Metab Cardiovasc Dis. 2016 Jan;26(1):1-8 [PMID: 26719220]
  52. Blood. 2013 Oct 17;122(16):2784-94 [PMID: 24009232]
  53. J Am Soc Nephrol. 2015 Oct;26(10 ):2399-413 [PMID: 25644111]
  54. Nat Chem Biol. 2011 Feb;7(2):75-7 [PMID: 21170021]
  55. Ren Fail. 2009;31(6):475-80 [PMID: 19839825]
  56. Invest Ophthalmol Vis Sci. 2014 Nov 18;55(12):7961-9 [PMID: 25406284]
  57. Sci STKE. 2007 Mar 27;2007(379):pe11 [PMID: 17392241]
  58. Nat Med. 2015 Jul;21(7):815-9 [PMID: 26076037]
  59. J Cell Biol. 2009 Jan 26;184(2):205-13 [PMID: 19153223]
  60. J Cell Biol. 2010 Nov 1;191(3):677-91 [PMID: 20974816]
  61. Proc Natl Acad Sci U S A. 2010 May 25;107(21):9813-8 [PMID: 20439745]
  62. PLoS Pathog. 2015 Jan 15;11(1):e1004593 [PMID: 25590621]
  63. Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5 [PMID: 20798043]
  64. Exp Dermatol. 2016 Nov;25(11):895-900 [PMID: 27307108]
  65. Kidney Res Clin Pract. 2015 Dec;34(4):201-6 [PMID: 26779422]
  66. Nat Med. 2009 Jun;15(6):623-5 [PMID: 19448636]
  67. J Thromb Haemost. 2015 May;13(5):732-42 [PMID: 25418346]
  68. Diabetes. 2014 Dec;63(12):4239-48 [PMID: 25092677]
  69. Cell Death Differ. 2009 Jan;16(1):3-11 [PMID: 18846107]
  70. Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1777-83 [PMID: 22652600]
  71. J Innate Immun. 2009;1(3):194-201 [PMID: 20375577]
  72. Lupus. 1999;8(1):68-76 [PMID: 10025601]
  73. Ann N Y Acad Sci. 2008 Aug;1137:296-301 [PMID: 18837963]
  74. J Leukoc Biol. 2007 Jan;81(1):1-5 [PMID: 17032697]

MeSH Term

Animals
Comorbidity
Extracellular Traps
Humans
Membranes, Artificial
Neutrophils
Renal Dialysis

Chemicals

Membranes, Artificial